These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, Penela M, Aguirrezábal X, Druet-Cabanac M, Medici M. Neuroepidemiology; 2008; 30(2):105-11. PubMed ID: 18334826 [Abstract] [Full Text] [Related]
4. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B, Winck JC, Azevedo LF. Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [Abstract] [Full Text] [Related]
5. Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina. Bettini M, Vicens J, Giunta DH, Rugiero M, Cristiano E. Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):598-603. PubMed ID: 23834086 [Abstract] [Full Text] [Related]
8. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register. Chiò A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, Ilardi A, Bertuzzo D, Bersano E, Cugnasco P, Grassano M, Pisano F, Mazzini L, Calvo A, Piemonte and Valle d’Aosta Register for ALS (PARALS). JAMA Neurol; 2017 Sep 01; 74(9):1097-1104. PubMed ID: 28692730 [Abstract] [Full Text] [Related]
10. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Kacem I, Sghaier I, Bougatef S, Nasri A, Gargouri A, Ajroud-Driss S, Gouider R. Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb 01; 21(1-2):131-139. PubMed ID: 31858811 [Abstract] [Full Text] [Related]
11. Clinical epidemiology of ALS in Liguria, Italy. Bandettini di Poggio M, Sormani MP, Truffelli R, Mandich P, Origone P, Verdiani S, Mantero V, Scialò C, Schenone A, Mancardi GL, Caponnetto C, LIGALS. Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan 01; 14(1):52-7. PubMed ID: 23030513 [Abstract] [Full Text] [Related]
12. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Punjani R, Wagner L, Horton K, Kaye W. Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb 01; 21(1-2):123-130. PubMed ID: 31795746 [Abstract] [Full Text] [Related]
14. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, Centers for Disease Control and Prevention (CDC). MMWR Suppl; 2014 Jul 25; 63(7):1-14. PubMed ID: 25054277 [Abstract] [Full Text] [Related]
15. Clinical features and incidence trends of amyotrophic lateral sclerosis in Navarre, Spain, 2007-2018: a population-based study. Jericó I, Elizalde-Beiras I, Pagola I, Torné L, Galbete A, Delfrade-Osinaga J, Vicente E. Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug 25; 22(5-6):401-409. PubMed ID: 33641502 [Abstract] [Full Text] [Related]
16. Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people. Broussalis E, Grinzinger S, Kunz AB, Killer-Oberpfalzer M, Haschke-Becher E, Hartung HP, Kraus J. Acta Neurol Scand; 2018 Mar 25; 137(3):329-334. PubMed ID: 29148035 [Abstract] [Full Text] [Related]